Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EZETIMIBE Cause Multiple organ dysfunction syndrome? 47 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Multiple organ dysfunction syndrome have been filed in association with EZETIMIBE (Ezetimibe). This represents 0.4% of all adverse event reports for EZETIMIBE.

47
Reports of Multiple organ dysfunction syndrome with EZETIMIBE
0.4%
of all EZETIMIBE reports
42
Deaths
41
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From EZETIMIBE?

Of the 47 reports, 42 (89.4%) resulted in death, 41 (87.2%) required hospitalization, and 32 (68.1%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EZETIMIBE. However, 47 reports have been filed with the FAERS database.

What Other Side Effects Does EZETIMIBE Cause?

Myalgia (2,066) Fatigue (876) Drug ineffective (812) Arthralgia (766) Dyspnoea (766) Nausea (742) Dizziness (717) Diarrhoea (688) Headache (626) Malaise (591)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which EZETIMIBE Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

EZETIMIBE vs EZETIMIBE\ROSUVASTATIN EZETIMIBE vs EZETIMIBE\SIMVASTATIN EZETIMIBE vs EZOGABINE EZETIMIBE vs FACTOR XIII CONCENTRATE EZETIMIBE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI

Related Pages

EZETIMIBE Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome EZETIMIBE Demographics